Episode 820: The Evolving Understanding of Periodontal Disease

The immune response, the release of cytokines, prostaglandins, and enzymes,
they're designed to fight infection. But in doing so, those inflammatory mediators also damage the
surrounding connective tissue and bone. In other words, much of the tissue destruction we see
clinically in periodontal disease is host-mediated. That understanding led to a major shift in
periodontal science. and ultimately influenced the classification systems used today.
Welcome to Austin, Texas, and welcome to the Dr. Phil Klein Dental Podcast. Before we jump into today's
conversation, we've got a quick favor to ask. If you're enjoying the show, hit that follow button,
whether it's Apple, Spotify, or whatever platform you use. And if you really want to help us out,
leave us a review. It only takes a minute. It helps us reach more dental professionals, bring you
more incredible guests, and keep the conversations coming. We really do appreciate it. If you've
been practicing dentistry for any length of time, you've probably noticed that the way we talk
about perio disease has slowly changed. Years ago, the explanation felt simple.
Perio disease was described as an infection. Bacteria accumulate around the teeth, inflammation
follows, bone is lost, and eventually teeth are compromised. Now, that model wasn't wrong,
but it also wasn't the full story. Today, the science around periodontal disease has evolved quite
a bit, and with that evolution has come a shift in how we define and manage the condition.
Increasingly, periodontal disease is being described not simply as an infection, but as a biofilm
-mediated inflammatory disease. And that change in language actually reflects a much deeper
understanding of what's really happening in the tissues surrounding our patient's teeth. So in this
episode, I want to take a few minutes to walk through how our understanding of period disease has
evolved. That's number one. And number two, why that matters. And then,
of course, number three, the big number three, what it means for the general dentist in everyday
clinical practice. So for many decades, periodontal disease was viewed primarily through the lens
of infection. The model was fairly straightforward. Dental plaque accumulates on the teeth.
That plaque contains bacteria. Those bacteria release toxins that irritate the surrounding gingival
tissues, inflammation follows, and if the process continues, it eventually leads to destruction of
the periodontal ligament and alveolar bone, the attachment apparatus. And also for many decades,
the treatment approach reflected that understanding. If bacteria are causing the problem, the goal
becomes removing bacteria. Hence, scaling and root planing, plaque control. antimicrobial rinses,
improved oral hygiene. And to be clear, those interventions remain foundational to periodontal
therapy today. But as microbiology advanced and researchers began studying the oral environment in
greater detail, it became clear that the story was more complicated than simply bacteria-caused
disease. One of the major turning points came with a deeper understanding of dental biofilm.
Hence the biofilm revolution. Dental plaque is not just a random collection of bacteria.
It's an organized, highly structured community of microorganisms that live together in what
scientists call a biofilm. Within this biofilm, bacteria communicate with one another,
share nutrients, and coordinate behavior in ways that make them far more resilient than individual
organisms floating freely in saliva. This concept completely changed how we think about microbial
infections in many areas of medicine, including dentistry. Inside a biofilm,
bacteria behave differently than they do in isolation. They become more resistant to
antimicrobials. They create protective extracellular matrices, and they adapt dynamically to the
environment. In the context of periodontal disease, This means the subgingival environment is not
simply colonized by a few harmful bacteria, as I said before. Instead, it becomes an ecological
system in which the balance of microbial species shifts over time,
and that shift is known as dysbiosis. One of the key insights in modern periodontal research is
that periodontal disease is not necessarily caused by a single pathogen invading healthy tissue.
Instead, it's the imbalance of the microbial community that drives disease progression.
That's really important, that imbalance of the microbial community. Again,
that's dysbiosis. In a healthy mouth, the oral microbiome contains hundreds of bacterial species
that coexist in a relatively stable equilibrium. But when that equilibrium is disrupted because of
plaque accumulation, host susceptibility, or environmental factors, certain pathogenic organisms
begin to dominate. Among the most studied are organisms like Porphyromonas gingivalis,
Troponema denticola, and Tanarella forsythia. These bacteria are often referred to collectively as
the red complex, but even these organisms don't act alone. One of the fascinating concepts that
emerged from periodontal research is that some pathogens act as keystone organisms.
They may not be present in large numbers, but they can alter the host immune response and reshape
the microbial ecosystem in ways that allow other harmful bacteria to flourish. So again,
the disease process is not simply infection. It's a microbial imbalance interacting with the host
immune system. And that brings us to the second half of the modern definition, inflammation.
One of the reasons periodontal disease behaves so differently among patients is that the host
response, the host immune response, varies dramatically from person to person.
You've probably seen this in your own practice. Two patients present with similar plaque levels.
One develops deep pockets and bone loss, and the other shows minimal destruction. Why?
Because periodontal destruction is not caused solely by bacteria. It's largely driven by the body's
inflammatory response. to those bacteria. In dental school, my pathology teacher gave us an example
of looking, he told us to look under our nails. And if you see dirt under your nails,
why don't you see inflammation? Why don't you see swelling? Because the body is not responding to
that bacteria that's under your nails. But if you took that same bacteria, for instance, and put it
somewhere else in your body, you might have a very robust immune response. And it's the immune
response. the release of cytokines, prostaglandins, and enzymes. They're designed to fight
infection. But in doing so, those inflammatory mediators also damage the surrounding connective
tissue and bone. In other words, much of the tissue destruction we see clinically in periodontal
disease is host-mediated. That understanding led to a major shift in periodontal science and
ultimately influenced the classification systems used today. Before we get back to our podcast,
I want to take a moment to thank our sponsor, EMS, the company behind guided biofilm therapy,
or GBT. If you haven't heard of it, GBT was developed with leading universities and clinicians,
and it's quickly becoming the gold standard for managing biofilm. What makes it so effective is the
minimally invasive evidence-based approach. With airflow, perioflow, and piezon technologies,
GBT gently removes biofilm, stains, and calculus with impressive precision.
Patients really notice the comfort and speed, and hygienists love how efficient the workflow
becomes. No surprise that thousands of practices worldwide are already seeing great results.
And EMS makes it easy to bring GBT into your practice with clinical guidance,
marketing support, and a clear plan for implementation. So check out the GBT-ready practice setup
at gbt-shop.us. So let's get into the modern definition.
Today, periodontal disease is widely described, as I mentioned, as a biofilm-mediated inflammatory
disease of the supporting structures of the teeth. the attachment apparatus. That language
emphasizes three key elements. First, biofilm, meaning the disease originates from a structured
microbial community rather than isolated bacteria. Second, inflammation,
meaning the host immune response plays an essential role in tissue destruction.
And third, susceptibility, meaning systemic and behavioral risk factors influence disease
progression. Now, this modern framework of these three things that I just mentioned was reflected
in the global periodontal classification system introduced at the 2017 World Workshop on the
classification of periodontal and peri-implant diseases and conditions. Here's what was
established at that workshop. Instead of older labels, we now break it into two key pieces,
stage and grade. Think of stage as how much damage has already been done. and grade as how fast the
disease is progressing. It gives clinicians a much clearer, more complete picture of what's
happening with the patient. So let's walk through the stages. Stage 1 is early disease,
minor attachment loss, minimal bone loss, and very manageable. Stage 2 steps that up to moderate
disease, with deeper pockets and more noticeable bone loss. Then you get into stage 3,
where things become severe, significant attachment loss. deeper defects, and even some tooth loss.
Finally, stage four is the most advanced, where not only is there severe destruction, but you're
also dealing with functional issues like bite collapse, drifting teeth, and need for complex
rehabilitation. Now the grading adds another layer. Grade A is slow-moving disease.
Grade B is what we'd consider typical progression. And grade C is where things get really
interesting and concerning. These are the fast movers. When you diagnose a patient at stage 3 or 4
with grade C, you're not just saying the disease is advanced. You're saying it's progressing
rapidly, often out of proportion to plaque levels. And that's where the biology shifts.
In these situations, we're seeing a hyper-inflammatory or dysregulated immune system,
where the patient's own response is driving much of the destruction. And that's why these cases
require closer monitoring and often a more aggressive, tailored treatment approach. So here's the
big question. Why does this shift in understanding matter for GPs? Because it changes how we
approach prevention, diagnosis, and long-term management. First, it reinforces that periodontal
disease is chronic and multifactorial. Scaling and root planing can reduce bacterial load.
But long-term stability requires controlling the factors that drive inflammation. That means
looking at the whole patient. Smoking status, metabolic health, glycemic control,
stress, sleep. All of these influence inflammatory pathways that can accelerate periodontal
breakdown. Second, it changes how we communicate with patients. If patients believe periodontal
disease is just an infection, They may assume, rightfully so, that a single deep cleaning will fix
it. But when we explain that it's an inflammatory condition influenced by their immune response,
it reframes the conversation. Now it becomes more of a partnership that they can help manage with
us long term, much like hypertension or diabetes. And that perspective often improves patient
compliance and ultimately clinical outcomes. So let's talk about some practical takeaways for the
GP. One of the most important is early detection. Because periodontal disease is often painless,
many patients don't realize anything is wrong until significant attachment loss has already
occurred. We see that all the time in the office. Routine periodontal charting, radiographic
evaluation, and careful assessment of bleeding on probing remain essential tools.
Bleeding in particular is a powerful clinical indicator. Healthy gingiva should not bleed with
gentle probing. Persistent bleeding is often a sign that inflammatory processes are active beneath
the surface. Another practical application involves risk assessment. Patients who smoke,
have uncontrolled diabetes, or demonstrate a history of rapid attachment loss may require more
aggressive monitoring and shorter recall intervals. We'll be right back in a second,
but first, for many years now, we've recognized that buffering local anesthetics can reduce
injection pain, speed up onset, and decrease the overall volume of anesthesia needed.
However, the process of buffering has always been complex, time-consuming, and expensive.
Until now. Introducing BufferPro. a single-use, sterile, self-contained capsule that delivers 0
.1 mils of sodium bicarbonate into a dental anesthetic cartridge, raising the solution's pH to near
physiologic levels. No measuring, no mixing, and no hassle. Join the growing number of dentists
introducing BufferPro into their practices. To learn more, visit septodontusa.com.
And these patients can benefit from close collaboration between general dentists and periodontal
specialists. And of course, maintenance therapy becomes critical because biofilm reforms quickly.
Periodontal stability often depends on consistent disruption of that biofilm through professional
cleanings, specific equipment that you can purchase for your office, and of course, effective home
care. And of course, we can't have this discussion without bringing up the oral systemic
connection. And that's another reason periodontal disease is receiving so much attention today.
in its potential connection to systemic health. Research in periodontology and systemic medicine
continues to explore links between periodontal inflammation and conditions like cardiovascular
disease, diabetes, adverse pregnancy outcomes, respiratory disease,
and so forth. So while cause and effect relationships are still being studied, the association
between periodontal inflammation and systemic inflammatory burden is becoming increasingly clear.
That places dentistry in an interesting position. For many patients, the dental office may be the
only health care setting where chronic inflammation is detected early, which means dentists and
hygienists play a critical role, not only in oral health, but in the overall health awareness of
the patient. So what is the future of periodontal care? As our understanding of periodontal disease
continues to evolve, New diagnostic and treatment approaches are emerging, things like microbial
testing, salivary diagnostics, host response biomarkers, and therapies that target inflammation
rather than just bacteria. These advances may eventually allow dentists to identify high-risk
patients earlier and tailor treatment strategies more precisely. But even with all the technology
on the horizon, the fundamentals remain remarkably consistent. Control biofilm,
reduce inflammation, address risk factors, and maintain long-term periodontal stability through
ongoing care. So here are my final thoughts on this. At its core, perio disease is a fascinating
example of how medicine evolves. What once seemed like a straightforward infection is now
understood as a complex interaction between microbes, the immune system,
and environmental influences. And that deeper understanding ultimately benefits patients because
when dentists view perio disease, as a biofilm-mediated inflammatory condition,
the focus shifts from simply treating pockets to managing health over time.
For the general dentist, that means continuing to emphasize early detection, patient education,
risk assessment, and collaborative care, not only with periodontists, but with the patient's
physicians. And perhaps most importantly, it reminds us that the tissues supporting the teeth are
part of a much larger biological system, one that reflects and is deeply connected to the patient's
overall health. So that's it for today, folks. Thank you so much for listening. I'm Dr. Phil Klein.
See you next time.